The United States abandoned the use of hydroxychloroquine in the treatment COVID-19

Us regulators withdrew permission for emergency use of antimalarial hydroxychloroquine for the treatment of patients with coronavirus infection. The reason for the revocation was a lack of data about the effectiveness of the drug for this indication, reports the BBC.

An emergency permit was issued by the FDA in March 2020. However, data from recent clinical studies indicate the lack of effectiveness of the antimalarial in the treatment of coronavirus infection.

Previously, the use of hydroxychloroquine refused the EU. European regulators made this decision due to security concerns: in an article published in The Lancet, said that in patients receiving hydroxychloroquine, it was observed an increased risk of death and heart rhythm disturbances.

Leave a Reply

Your email address will not be published. Required fields are marked *


For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]